SEC Form 4 · accession 0001376043-15-000004
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Amir Nashat
Director · 10% Owner
Period of report
May 13, 2015
Accepted (ET)
May 15, 2015 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $7.08 | May 13, 2015 | A | 10,000 | A | — | May 12, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable on the earlier of (i) May 13, 2016 or (ii) the date of the 2016 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.
- F2Not applicable.